Israel Biotech Fund
Overview
Israel Biotech Fund invests exclusively in Israeli and Israeli related biotech companies at all development stages. The fund is committed to seeking high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotechnology companies. IBF provides its portfolio companies with hands-on guidance and the necessary resources for long-term sustainable growth.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biond Biologics | Jan 2019 | Series B | Lead |
| Coltac Therapeutics | Apr 2022 | Seed | Co-investor |
| Vensica Medical | Oct 2024 | VC Round | Lead |
| Cellyrix Therapeutics | Dec 2024 | Seed | Co-investor |
| Ukko | Jan 2026 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Yuval Cabilly
Managing Partner
Ido Zairi
General Partner
Sarit Steinberg
Partner
Benjamin Maisano
Fund Advisor Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Israel Biotech Fund based?
Israel Biotech Fund is headquartered in Israel.
When was Israel Biotech Fund founded?
Israel Biotech Fund was founded in 2014.
How many portfolio companies does Israel Biotech Fund have?
Israel Biotech Fund has 11 portfolio companies in Caplight's dataset.
What are some companies in Israel Biotech Fund's portfolio?
Portfolio companies visible on Caplight include Biond Biologics, Coltac Therapeutics, Vensica Medical, Cellyrix Therapeutics, Ukko.
What was Israel Biotech Fund's most recent investment shown here?
Israel Biotech Fund's most recent investment in this portfolio sample was in Ukko in 2026.
What sectors does Israel Biotech Fund focus on?
Israel Biotech Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Israel Biotech Fund focus on?
Israel Biotech Fund typically invests at the MultiStage stage.
What is Israel Biotech Fund's AUM?
Israel Biotech Fund's assets under management are estimated between $100.0M and $250.0M.